Molecular tests are becoming more routine as diagnostic tools, with many now covered by Medicare and commercial insurers. Advantages of molecular tests based on PCR technology include their ability to identify uropathogens traditionally missed by culture-based tests.
Driven by urgent, unmet analytical and clinical care needs, the adoption of the rapid molecular test—particularly RT-PCR for urinary tract infection control and treatment—has important implications.
This white paper – the third in a three-part series developed in collaboration with Mayo Clinic Laboratories and Change Healthcare – provides frontline perspective and commentary from experts and physicians on the application and value of decision support in the laboratory. It also includes early-adopter proof points from hospital laboratories that have successfully implemented third-party decision support to achieve their stewardship goals, including EHR interventions and ongoing monitoring of utilization.
Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and timely, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.
As a member of your laboratory’s leadership team, learn what you need to know as a competitive laboratory to maximize efficiency, increase profitability, and decrease costs over the long run by leveraging effective medical courier services and those that utilize digital technologies.
This white paper—part 2 of a three-part series— provides practical pearls on how a proven decision support solution and one that is a good fit for your lab can be the foundation of an effective laboratory stewardship program, and can greatly assist in controlling utilization and meeting the challenges of value-based care. As well, the paper also clearly explains the points for “buy versus build” laboratory decision support.
Choosing the right decision support solution will empower your lab and hospital leaders, clinicians, and staff with more time to focus their core competencies on the provision of healthcare. Learn what you need to know by downloading this FREE whitepaper now.
Driven by recent technological and regulatory approvals, leading academic and commercial laboratories are increasingly going digital to overcome significant gaps in efficiency and diagnostic accuracy. These same labs are implementing computational applications that leverage artificial intelligence (AI) to expand on the productivity, quality, and confidence gains they’ve already realized.
Download the White Paper now to get a synopsis of recent research and real-world cases that demonstrate the economic and scientific necessity of adopting digital pathology platforms and AI applications. Gather perspective from in-depth interviews with industry-leading labs that lay out the benefits they themselves gained from going digital.